New Delhi, May 28: Any significant adverse effect is unlikely if the second dose of a different COVID-19 vaccine is administered, but reaching a firm opinion on this will need more scrutiny and understanding, the Centre said on Thursday.
It, however, clarified that both doses administered to an individual should be of the same vaccine as per the existing protocol.
The clarification comes following reports that health workers in Uttar Pradesh’s Siddharthnagar district administered Covaxin to 20 villagers who had been given Covishield in the first dose.
NITI Aayog member (Health) V K Paul said the incident needed to be investigated.
“Any significant adverse effect is unlikely if the second dose of a different COVID-19 vaccine is given. In fact, there is a narrative that is going on that taking doses…